Recommending revised hepatoblastoma surveillance in children with a pathogenic ARID1A variant. Reply to "Cancer in ARID1A-Coffin-Siris syndrome: Review and report of a child with hepatoblastoma" by Cárcamo et al. 2022

Affiliations

• ¹ Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands; Division of Medical Genetics and Metabolism, Children's Hospital of the King's Daughters, Norfolk, VA, USA; Department of Pediatrics, Eastern Virginia Medical School, Norfolk, VA, USA; Department of Pediatrics, Baylor College of Medicine, San Antonio, TX, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Genetics, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
• ² Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands; Division of Medical Genetics and Metabolism, Children's Hospital of the King's Daughters, Norfolk, VA, USA; Department of Pediatrics, Eastern Virginia Medical School, Norfolk, VA, USA; Department of Pediatrics, Baylor College of Medicine, San Antonio, TX, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Genetics, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: G.W.E.Santen@LUMC.nl.